WEDNESDAY, Feb. 18 (HealthDay News) — New tobacco company marketing campaigns that target women and girls are the most aggressive in more than a decade, a new report concludes.
That marketing needs to be curbed by giving the U.S. Food and Drug Administration authority over tobacco products, according to the report, released Wednesday by a coalition of major U.S. public health organizations.
Campaigns launched in recent years by the nation’s two Read the rest of this entry »

CORNELIUS, N.C. — In the waning days of the Bush administration, the Food and Drug Administration finalized new guidelines to make it easier for drug manufacturers to promote “off-label” prescription drug uses, which can be deadly.
The move came despite criticism from then-President George W. Bush’s Department of Veterans Affairs, which said the change “favors business interests over public safety” and could lead to a “decline in drug Read the rest of this entry »

Online marketing is the wave of the future. With millions of individuals constantly tapping into the Internet, it is no wonder fitness professionals are looking for more and more ways to develop an online presence. To market a fitness business properly, you must understand a few details about the Internet itself. Every mistake made will translate into a loss of leads, referrals, and the change to close a sale. Don’t let your attempt to market a Read the rest of this entry »

(RTTNews) - 
Wednesday, disposable device maker Merit Medical Systems, Inc. (MMSI:
), announced 510-k clearance from the U.S. FDA to market Prelude Short Sheath Introducer. Merit said sales would commence worldwide in the next few weeks.
South Jordan, Utah-based Merit Medical indicated the Prelude Short Sheath Introducer as a device used primarily for access to dialysis fistulas and grafts. The device is expected Read the rest of this entry »

The federal Food and Drug Administration has told Burlington-based Laboratory Corporation of America Holdings that it is violating the law by selling a test for ovarian cancer without regulatory approval.
In a letter dated Sept. 29, Steven I. Gutman, director in the office of In Vitro Diagnostic Device Evaluation and Safety with the FDA, wrote to LabCorp president and CEO David P. King that the company’s OvaSure has not received proper approval.
Read the rest of this entry »

(RTTNews) - 
Power Medical Interventions, Inc. (PMII:
) said the U.S. Food and Drug Administration has cleared its 510(k) application for marketing its patented i60RL Intelligent Surgical Instrument.
The i60RL Intelligent Surgical Instrument is designed to improve medical outcomes by providing surgeons with greater access to important anatomical sites that are currently difficult to reach.
The company said Read the rest of this entry »

WASHINGTON (AP) — Aspirin medicines from Bayer intended to promote healthy hearts and stronger bones are being illegally marketed with unproven health claims, federal regulators said Tuesday.
.
Treatments for those diseases must be reviewed by government scientists and cannot be sold over the counter, the food and drug agency said. Doctors recommend aspirin to treat aches and pains and as a blood thinner for patients with heart disease.
Read the rest of this entry »

Adaptive Marketing Gives Tips on How to Stay in Shape on the Road.
Norwalk, CT (
) September 15, 2008 –
®, an industry leader in membership programs, knows how tough it can be to stay in shape, especially if work requires a lot of travel. After all, business trips call for frequent meetings, company events and little free time. But finding creative and fun ways to burn calories while traveling is a practiced art.
advises making general Read the rest of this entry »

Washington is getting $1.2 million as part of a $60 million, 33-state settlement with Pfizer Inc. over potentially dangerous marketing practices.
The agreement reached today ends a five-year investigation into allegations that the company marketed anti-inflammatory drugs Celebrex and Bextra for unapproved uses despite known health risks.
“This isn’t just deceptive marketing; ‘off-label’ marketing can create a potential health risk to patients,” Read the rest of this entry »

Posted on Sunday, 2 of November , 2008 at 5:56 pm
WASHINGTON, DC—The U.S. Food and Drug Administration has sent warning letters to Bayer HealthCare concerning two unlawful, over-the-counter (OTC) aspirin products — Bayer Women’s Low Dose Aspirin + Calcium (Bayer Women’s) and Bayer Aspirin with Heart Advantage
(Bayer Heart Advantage).
The products, which contain aspirin with either phytosterols or calcium, are unapproved new Read the rest of this entry »